Cedric O'Gorman
Net worth: 47 063 $ as of 2024-03-30
Profile
Cedric O'Gorman worked as Senior VP-Clinical Development & Medical Affairs at Axsome Therapeutics, Inc. from 2017 to 2021.
Prior to that, he was Vice President-Medical Affairs at Intra-Cellular Therapies, Inc. from 2014 to 2017.
He will be Chief Medical Officer at Relmada Therapeutics, Inc. in 2023 and was Chief Medical Officer at Alpha Cognition, Inc. from 2021 to 2023.
O'Gorman holds a doctorate from the National University of Ireland and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RELMADA THERAPEUTICS INC
0.03% | 2023-05-22 | 10,121 ( 0.03% ) | 47 063 $ | 2024-03-30 |
Former positions of Cedric O'Gorman
| Companies | Position | End |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-01-02 |
| ALPHA COGNITION INC. | Chief Tech/Sci/R&D Officer | 2023-01-05 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-12-01 |
| INTRA-CELLULAR THERAPIES, INC. | Chief Tech/Sci/R&D Officer | 2017-08-31 |
Training of Cedric O'Gorman
| National University of Ireland | Doctorate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AXSOME THERAPEUTICS, INC. | Health Technology |
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| RELMADA THERAPEUTICS, INC. | Health Technology |
| ALPHA COGNITION INC. | Health Technology |
- Stock Market
- Insiders
- Cedric O'Gorman
